Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeffrey Stein Insider Profile
25 Followers
Jeffrey Stein, President & CEO, Director at Cidara Therapeutics, holds 84.56K shares in Cidara Therapeutics (Ticker: CDTX), holds 0.00 shares in Paratek Pharmaceuticals (Ticker: PRTK), holds ― shares in IDEAYA Biosciences (Ticker: IDYA). Most recently, Jeffrey Stein Bought ― shares of Cidara Therapeutics on Jun 11, 2024 for an estimated value of 105.68K.
Jeffrey Stein Cidara Therapeutics (CDTX)President & CEO, Director
Cidara Therapeutics (CDTX)
President & CEO, Director
Ranked #84,012 out of 100,202 Corporate Insiders
Profitable Transactions
2 out of 11 Profitable Transactions
Average Return
-16.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeffrey Stein holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jeffrey Stein
Jeffrey Stein's Trading History
Cidara Therapeutics
Jun 11, 2024
President & CEO, Director
Informative Buy
105.68K
$1.96M
Paratek Pharmaceuticals
Sep 21, 2023
―
Uninformative Sell
―
$0.00
IDEAYA Biosciences
―
Director
―
―
Trius Therap
Aug 02, 2010
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Jeffrey Stein's performance on stock
You May Also Like
Jeffrey Stein insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Stein?
The percentage of profitable transactions made by Jeffrey Stein is 18%.
What is the average return per transaction made by Jeffrey Stein?
The average return per transaction made by Jeffrey Stein is -16.40%.
What stocks does Jeffrey Stein hold?
Jeffrey Stein holds: CDTX, PRTK, IDYA, TSRX stocks.
What was Jeffrey Stein’s latest transaction?
Jeffrey Stein latest transaction was an Informative Buy of $105.68K.
What was Jeffrey Stein's most profitable transaction?
Jeffrey Stein’s most profitable transaction was an Informative Buy of CDTX stock on June 11, 2024. The return on the trade was 71.30%.
What is Jeffrey Stein's role in Cidara Therapeutics?
Jeffrey Stein's role in Cidara Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.